Reconciling global-model estimates and country reporting of anthropogenic forest CO2 sinks

This is the author accepted manuscript. The final version is available from Springer Nature via the DOI in this recordData availability: The data that support the findings of this study are available from the corresponding author upon request.Achieving the long-term temperature goal of the Paris Agreement requires forest-based mitigation. Collective progress towards this goal will be assessed by the Paris Agreement’s Global stocktake. At present, there is a discrepancy of about 4 GtCO2yr−1in global anthropogenic net land-use emissions between global models (reflected in IPCC assessment reports) and aggregated national GHG inventories (under the UNFCCC). We show that a substantial part of this discrepancy (about 3.2 GtCO2yr−1) can be explained by conceptual differences in anthropogenic forest sink estimation, related to the representation of environmental change impacts and the areas considered as managed. For a more credible tracking of collective progress under the Global stocktake, these conceptual differences between models and inventories need to be reconciled. We implement a new method of disaggregation of global land model results that allows greater comparability with GHG inventories. This provides a deeper understanding of model–inventory differences, allowing more transparent analysis of forest-based mitigation and facilitating a more accurate Global stocktake.J.H. was supported by EU FP7 through project LUC4C (GA603542) and the UK NERC project GGRiLS-GAP. G.G. was supported by Administrative Arrangement Number 340203/2016/742550/SER/CLIMA.A3. A.K.J. was supported by the NSF (AGS 12-43071) and DOE (DE-SC0016323). J.E.M.S.N. was supported by the German Research Foundation’s Emmy Noether Programme (grant number PO1751/1-1). G.G., J.H., G.P.P. and L.P. received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 776810 (VERIFY). C.D.K. was supported by the US DOE under Contract DE-AC02-05CH11231 as part of their RGMA (BGC-Feedbacks SFA) and TES Programs (NGEE-Tropics). A.K.J. was supported under the US NSF (NSF-AGS-12-43071)

p-Glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistance

<p>Abstract</p> <p>Background</p> <p>Cancer cells recurrently develop into acquired resistance to the administered drugs. The iatrogenic mechanisms of induced chemotherapy-resistance remain elusive and the degree of drug resistance did not exclusively correlate with reductions of drug accumulation, suggesting that drug resistance may involve additional mechanisms. Our aim is to define the potential targets, that makes drug-sensitive MCF-7 breast cancer cells turn to drug-resistant, for the anti-cancer drug development against drug resistant breast cancer cells.</p> <p>Methods</p> <p>Doxorubicin resistant human breast MCF-7 clones were generated. The doxorubicin-induced cell fusion events were examined. Heterokaryons were identified and sorted by FACS. In the development of doxorubicin resistance, cell-fusion associated genes, from the previous results of microarray, were verified using dot blot array and quantitative RT-PCR. The doxorubicin-induced expression patterns of pro-survival and pro-apoptotic genes were validated.</p> <p>Results</p> <p>YB-1 and ABCB5 were up regulated in the doxorubicin treated MCF-7 cells that resulted in certain degree of genomic instability that accompanied by the drug resistance phenotype. Cell fusion increased diversity within the cell population and doxorubicin resistant MCF-7 cells emerged probably through clonal selection. Most of the drug resistant hybrid cells were anchorage independent. But some of the anchorage dependent MCF-7 cells exhibited several unique morphological appearances suggesting minor population of the fused cells maybe de-differentiated and have progenitor cell like characteristics.</p> <p>Conclusion</p> <p>Our work provides valuable insight into the drug induced cell fusion event and outcome, and suggests YB-1, GST, ABCB5 and ERK3 could be potential targets for the anti-cancer drug development against drug resistant breast cancer cells. Especially, the ERK-3 serine/threonine kinase is specifically up-regulated in the resistant cells and known to be susceptible to synthetic antagonists.</p

Challenges in multidisciplinary cancer care among general surgeons in Canada

<p>Abstract</p> <p>Background</p> <p>While many factors can influence the way that cancer care is delivered, including the way that evidence is packaged and disseminated, little research has evaluated how health care professionals who manage cancer patients seek and use this information to identify whether and how this could be supported. Through interviews we identified that general surgeons experience challenges in coordinating care for complex cancer patients whose management is not easily addressed by guidelines, and conducted a population-based survey of general surgeon information needs and information seeking practices to extend these findings.</p> <p>Methods</p> <p>General surgeons with privileges at acute care hospitals in Ontario, Canada were mailed a questionnaire to solicit information needs (task, importance), information seeking (source, frequency of and reasons for use), key challenges and suggested solutions. Non-responders received up to three reminder packages. Significant differences among sub-groups (age, setting) were examined statistically (Kruskal Wallis, Mann Whitney, Chi Square). Standard qualitative methods were used to thematically analyze open-ended responses.</p> <p>Results</p> <p>The response rate was 44.2% (170/385) representing all 14 health regions. System resource constraints (60.4%), comorbidities (56.4%) and physiologic factors (51.8%) were top-ranked issues creating information needs. Local surgical colleagues (84.6%), other local colleagues (82.2%) and the Internet (81.1%) were top-ranked sources of information, primarily due to familiarity and speed of access. No resources were considered to be highly applicable to patient care. Challenges were related to limitations in diagnostics and staging, operative resources, and systems to support multidisciplinary care, together accounting for 76.0% of all reported issues. Findings did not differ significantly by surgeon age or setting of care.</p> <p>Conclusion</p> <p>General surgeons appear to use a wide range of information resources but they may not address the complex needs of many cancer patients. Decision-making is challenged by informational and logistical issues related to the coordination of multidisciplinary care. This suggests that limitations in system capacity may, in part, contribute to variable guideline compliance. Further research is required to evaluate the appropriateness of information seeking, and both concurrent and consecutive mechanisms by which to achieve multidisciplinary care.</p